WeRide announced on March 3 2026 that it would suspend its robotaxi fleet in Dubai in response to the escalating Middle East conflict that began on February 28 and intensified with U.S.–Israel strikes on March 1 and 2. The suspension was a direct reaction to the heightened security environment and the disruption of transportation infrastructure in the region.
The pause stops revenue generation from Dubai, a key component of WeRide’s Middle East expansion plan. The company had launched public operations with Uber in Dubai in December 2025 and had set a target of 1,200 robotaxis across the region by 2027. The suspension therefore delays a significant portion of that growth trajectory.
Operations in Abu Dhabi and Riyadh remain active, illustrating a targeted response to the Dubai situation. The company has advised employees to work from home and limit non‑essential travel, underscoring its focus on safety and regulatory compliance amid the conflict.
The move highlights the geopolitical risks that autonomous mobility firms face in volatile regions. While the suspension temporarily reduces revenue, it preserves the company’s long‑term presence and protects its workforce, mitigating potential losses from operating in an unsafe environment.
Industry peers such as Baidu’s Apollo Go and Pony.ai are also monitoring the situation. Apollo Go is coordinating with local regulators, and Pony.ai has resumed testing in Doha while planning a later restart in Dubai, indicating a broader industry impact.
WeRide’s partnership with Uber and its planned fleet expansion underscore the strategic importance of Dubai. The suspension may delay the 2027 scaling target but does not alter the company’s overall Middle East strategy, which continues to focus on expanding operations in other regional hubs.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.